Open Access News

News from the open access movement


Friday, October 14, 2005

BMC responds to the Kaufman-Wills report

BioMed Central has released a response (October 14) to the Kaufman-Wills report published by ALPSP. Excerpt:
BioMed Central welcomes objective research into open access publishing. Unfortunately, however, the report published by ALPSP this week ("The Facts about Open Access") contains significant factual inaccuracies. We also disagree with many of the reports interpretations and conclusions. The two most serious problems with the report are that it inaccurately describes the peer review process operated by BioMed Central's journals, and it also draws unjustified conclusions concerning the long-term sustainability of open access journals. The overview of the report incorrectly states that BioMed Central does not operate external peer review on most of its journals. In fact, all of BioMed Central's journals operate full peer review using external peer reviewers....the BioMed Central/ISP group of journals is reported to offer online manuscript submission on a lower percentage of journals than other journal groups. The report picks up on this as a surprising finding, suggesting implicitly that open access journals are lagging behind in this regard. In fact, BioMed Central offers online submission of manuscripts on every one of its journals. Not only that, but BioMed Central's manuscript submission system is widely praised by authors, many of whom tell us that it is the best online submission system they have used....

ALPSP Chief Executive Sally Morris comments in her introduction to the report that "Over 40% of the Open Access journals are not yet covering their costs and, unlike subscription journals, there is no reason why the passage of time - evidenced in increasing submissions, quality or impact - should actually change that". She goes on to suggest that this calls into question the sustainability of the open access publishing model. The suggestion that the economics of open access journals are unlikely to improve over time is not supported by the evidence in the report, and runs strongly counter to BioMed Central's direct experience. According to BioMed Central Publisher, Dr Matthew Cockerill, "The fact that many open access journals currently operate at a loss is simply a sign that these are early days. There is every reason to think that the passage of time will profoundly improve the ability of open access journals to cover their costs. Between September 2004 and September 2005, for example, the journal BMC Bioinformatics almost trebled the number of submissions it received. It also increased its article processing charge during that same time period. Both factors have helped move BioMed Central much closer to overall profitability, and this progress is continuing."

Further evidence for a promising future for open access journals is given in the study's findings on revenue expectations and trends. 92% of open access journals were meeting or exceeding revenue expectations, in comparison to 91% of AAMC journals, 83% of ALPSP journals and 76% of surveyed HighWire journals. Similarly, the study finds that revenues from the last fiscal year to the current fiscal year are "trending upward" for 71% of 209 surveyed open-access journals, compared to between 27% and 67% of subscription-based publishers that were surveyed.